AI in the Lab: Where It's Actually Working (and Where It's Not)

<p>AI is already changing lab diagnostics - but not where most people think. The real wins are happening in reimbursement, prior auth, claim support, data reporting, and clinical trial workflows, while the flashier promise of AI-assisted pathology is still moving much slower than the sales pitches suggest.Melissa Butterworth cuts through the hype and zeroes in on what lab leaders, hospital executives, and advisors need to know before signing on to another AI vendor promise. If you are trying to decide whether AI is a true operational partner or just the latest cost-centered buzzword, this episode gives you the signal inside the noise.You will hear why AI adoption is gaining traction fastest in the back office, where ROI is immediate and measurable, and why pharma and biotech-facing labs are using AI to streamline patient recruitment and sample handling. You will also hear where the technology is still stuck, what vendors often leave out about digital pathology, and why data privacy and governance need real answers, not marketing language.Melissa also breaks down the cultural barrier that can make or break an implementation: when hospital leadership treats the lab like a cost center instead of a strategic asset, even the smartest tools struggle to get funded, supported, and scaled. She explains how lab leaders can strengthen the business case, refine workflows around the tool, and communicate upward to the C-suite in a way that gets attention.If you are evaluating AI for a lab, advising a health system, or trying to understand where this technology is actually delivering value today, this is essential listening. The episode leaves you with a sharper framework for separating real progress from hype, and for asking the questions that matter before the budget is decided.</p>